Rehabilitation Robotics
Rehabilitation robotics bridging Japanese engineering and European clinics.
- Sector
- Robotics
- Country
- Japan–Europe
- Year
- 2025
- Status
- Active
Catalyst roleEuropean Partner · Co-Investment · Market Development
Presented without company name or transaction figures. Amounts, investor names and commercial details are confidential under NDA.
The opportunity
Advanced rehabilitation and healthcare robotics developed in Japan need a structured path into European clinical markets — and European capital that understands long-term partnership.
The company
A developer of robotic technologies for rehabilitation and healthcare, combining Japanese engineering depth with clinical application.
Catalyst role
Catalyst acts as European partner and co-investor — coordinating market development, clinical introductions and a cross-border investment structure.
Development strategy
Treat the relationship as a strategic partnership, not a transaction: continuity, quality and long-term capital over a single round.
Investment architecture
One project. Multiple layers of capital.
The capital structure was assembled to fit the asset — combining the layers below.
Milestones
- 01PartnershipEurope–Japan co-investment structure agreed.
- 02Clinical entryFirst European rehabilitation pilots.
- 03DistributionBuilding European distribution relationships.
Gallery
Representative imagery. Confidential material — valuation, shareholder information, exact IRR, commercial contracts and investor names — is not published without permission.
Building something that belongs here?
Submit a company or an infrastructure project for review.